
doi: 10.1002/agt2.270
AbstractDigital light processing (DLP)‐based bioprinting technology has recently aroused considerable concerns as a strategy to deliver biomedical materials and/or specific cells to create sophisticated structures for various tissue modeling and regeneration. In this review, we display a concise introduction of DLP bioprinting, and a further discussion on the design and manufacture of DLP (bio)printer with varied bioinks and their biomedical applications toward drug screening, disease modeling, tissue repair, and regenerative medicine. Finally, the advantages, challenges, and perspectives of the DLP printing platforms are detailed. It is believed that DLP bioprinting will play a decisive role in the field of tissue model and regenerative medicine, mainly due to its time‐efficient, higher resolution, and amenability to automation for various tissue needs.
Chemistry, QH301-705.5, disease modeling, DLP bioprinting, drug screening, Biology (General), QD1-999, tissue modeling
Chemistry, QH301-705.5, disease modeling, DLP bioprinting, drug screening, Biology (General), QD1-999, tissue modeling
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 78 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
